Skip to main content
PMC home page
Japanese Journal of Cancer Research : Gann logoLink to Japanese Journal of Cancer Research : Gann
. 1997 Sep;88(9):815–820. doi: 10.1111/j.1349-7006.1997.tb00456.x

Regressive Effects of Various Chemopreventive Agents on Azoxymethane‐induced Aberrant Crypt Foci in the Rat Colon

Yukio Morishita 1, Naoki Yoshimi 1, Kunihiro Kawabata 1, Kengo Matsunaga 1, Shigeyuki Sugie 1, Takuji Tanaka 1, Hideki Mori 1,✉
PMCID: PMC5921511  PMID: 9369928

Abstract

Regressive effects of four chemopreventive agents [5‐hydroxy‐4‐(2‐phenyl‐(E)‐ethenyl)‐2(5Hfura‐none (KYN‐54), S‐methyl metbanethiosulfonate (MMTS), chlorogenic acid (CA), and piroxicam] on azoxymethane (AOM)‐induced aberrant crypt foci (ACF) in the colon of male F344 rats were examined by dietary exposure. At six weeks of age, 60 rats of groups 1 through 5 received subcutaneous injections of AOM (15 mg/kg body weight) once a week for three weeks. Twelve weeks after the first carcinogen injection, wben the occurrence of ACF was maximal, the rats in groups 2 through 5 were started on diet containing the test chemicals as follows: group 2, KYN‐54 (0.02%); group 3, MMTS (0.01%); group 4, CA (0.025%); and group 5, piroxicam (0.0125%). Group 1 (20 rats) was kept on the basal diet alone, and group 6 (12 rate) served as an untreated control. Rats in each group were killed at 6, 12, 18, or 24 weeks after the start of the experiment, and the yield of ACF in the colon of each group at 18 or 24 weeks was compared with that at 12 weeks. The number of ACF per rat colon of each group at 18 or 24 weeks was smaller than that at 12 weeks. The reduction rates at 18 weeks were 7% in group 1 (AOM alone), 11% in group 2 (AOM+KYN‐54), 10% in group 3 (AOM+MMTS), 51% in group 4 (AOM + CA) (P 0.01), and 33% in group 5 (AOM+piroxicam) (P<0.02), while at 24 weeks they were 12%, 26%, 51% (P<0.002), 43% (P <0.05), and 70% (P <0.001), respectively. These results indicate that chemopreventive agents for large bowel carcinogenesis, i.e., KYN‐54, MMTS, CA, and piroxicam, are not only able to prevent the development of ACF, but also can regress ACF, which are regarded as precursor lesions of colorectal cancer.

Keywords: Regression, Chemoprevention, Azoxymethane, Aberrant crypt foci, Colon

Full Text

The Full Text of this article is available as a PDF (324.5 KB).

REFERENCES

  • 1. ) Wattenberg , L. W.Chemoprevention of cancer . Cancer Res. , 45 , 1 – 8 ( 1985. ). [PubMed] [Google Scholar]
  • 2. ) Wattenberg , L. W.Inhibitors of chemical carcinogens . Adv. Cancer Res. , 26 , 197 – 226 ( 1978. ). [DOI] [PubMed] [Google Scholar]
  • 3. ) Mori , H. , Tanaka , T. , Sugie , S. and Yoshimi , N.Chemo‐preventive effects of plant derived phenolic, organosulfur and other compounds on carcinogenesis in digestive organs . Environ. Mutagen Res. Commun. , 17 , 127 – 133 ( 1995. ). [Google Scholar]
  • 4. ) Kingsnorth , A. N. , King , W. W. K. , Diekema , K. A. , McCann , P. P. , Ross , J. S. and Malt , R. A.Inhibition of ornithine decarboxylase with 2‐difhioromethylornithine: reduced incidence of dimethylhydrazine‐induced colon tumors in mice . Cancer Res. , 43 , 2545 – 2549 ( 1983. ). [PubMed] [Google Scholar]
  • 5. ) Reddy , B. S. , Maruyama , H. and Kelloff , G.Dose‐related inhibition of colon carcinogenesis by dietary piroxicam, a nonsteroidal anti‐inflammatory drug, during different stages of rat colon tumor development . Cancer Res. , 47 , 5340 – 5346 ( 1987. ). [PubMed] [Google Scholar]
  • 6. ) McLellan , E. A. and Bird , R. P.Aberrant crypts: potential preneoplastic lesions in the murine colon . Cancer Res. , 48 , 6187 – 6192 ( 1988. ). [PubMed] [Google Scholar]
  • 7. ) Bird , R. P.Role of aberrant crypt foci in understanding the pathogenesis of colon cancer . Cancer Lett. , 93 , 55 – 71 ( 1995. ). [DOI] [PubMed] [Google Scholar]
  • 8. ) Pretlow , T. P. , Barrow , B. J. , Ashton , W. S. , O'Riordan , M. A. , Pretlow , T. G. , Jurcisek , J. A. and Stellato , T. A.Aberrant crypts: putative preneoplastic foci in human co‐Ionic mucosa . Cancer Res. , 51 , 1564 – 1567 ( 1991. ). [PubMed] [Google Scholar]
  • 9. ) Bird , R. P.Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: preliminary findings . Cancer Lett. , 37 , 147 – 151 ( 1987. ). [DOI] [PubMed] [Google Scholar]
  • 10. ) Kawamori , T. , Tanaka , T. , Hara , A. , Yamahara , J. and Mori , H.Modifying effects of naturally occurring products on the development of colonic aberrant crypt foci induced by azoxymethane in F344 rats . Cancer Res. , 55 , 1277 – 1282 ( 1995. ). [PubMed] [Google Scholar]
  • 11. ) Pereira , M. A. , Barnes , L. H. , Steele , V. E. , Kelloff , O. V. and Lubet , R. A.Piroxicam‐induced regression of azoxy‐methane‐induced aberrant crypt foci and prevention of colon cancer in rats . Carcinogenesis , 17 , 373 – 376 ( 1996. ). [DOI] [PubMed] [Google Scholar]
  • 12. ) Kawamori , T. , Tanaka , T. , Suzui , M. , Okamoto , K. , Tamai , Y. , Torihara , M. , Yamahara , J. and Mori , H.Chemoprevention of azoxymethane‐induced intestinal carcinogenesis by a novel synthesized retinoidal butenolide, 5‐hydroxy‐4‐(2‐phenyl‐(E)‐ethenyl)‐2(5H)‐furanone, in rats . Carcinogenesis , 16 , 795 – 800 ( 1995. ). [DOI] [PubMed] [Google Scholar]
  • 13. ) Kawamori , T. , Tanaka , T. , Ohnishi , M. , Hirose , Y. , Nakamura , Y. , Satoh , K. , Hara , A. and Mori , H.Chemoprevention of azoxymethane‐induced colon carcinogenesis by dietary feeding of S‐methyl methane thiosulfonate in male F344 rats . Cancer Res. , 55 , 4053 – 4058 ( 1995. ). [PubMed] [Google Scholar]
  • 14. ) Mori , H. , Tanaka , T. , Shima , H. , Kuniyasu , T. and Takahashi , M.Inhibitory effect of chlorogenic acid on methylazoxymethanol acetate‐induced carcinogenesis in large intestine and liver of hamsters . Cancer Lett. , 30 , 49 – 54 ( 1986. ). [DOI] [PubMed] [Google Scholar]
  • 15. ) Mori , H. , Yoshimi , N. , Tanaka , T. and Hirose , Y.Experimental colorectal carcinogenesis: role of cell proliferation . In “ Recent Advances in Gastroenterological Carcinogenesis I,” ed. Tahara E. , Sugimachi K. and Oohara T. , pp. 249 – 253 ( 1996. ). Monduzzi Editore; , Bologna . [Google Scholar]
  • 16. ) Kawamori , T. , Tanaka , T. , Hirose , Y. , Satoh , K. , Hara , A. , Torihara , M. , Tamai , Y. , Yamahara , J. and Mori , H.Suppression of azoxymethane‐induced colonic aberrant crypt foci by dietary exposure to a novel synthesized retinoidal butenolide, 5‐hydroxy‐4‐(2‐phenyl‐(E)ethenyl)‐2(5H)‐furanone, in rats . Cancer Lett. , 92 , 159 – 165 ( 1995. ). [DOI] [PubMed] [Google Scholar]
  • 17. ) Pereira , M. A. , Barnes , L. H. , Rassman , V. L. , Kelloff , G. V. and Steele , V. E.Use of azoxymethane‐induced foci of aberrant crypts in rat colon to identify potential cancer chemopreventive agents . Carcinogenesis , 15 , 1049 – 1054 ( 1994. ). [DOI] [PubMed] [Google Scholar]
  • 18. ) Kasai , H. , Chung , M.‐H. , Yamamoto , F. , Ohtsuka , E. , Laval , J. , Grollman , A. P. and Nishimura , S.Formation, inhibition of formation, and repair of oxidative 8‐hydroxy‐guanine DNA damage . In “ Antimutagenesis and Anti‐carcinogenesis Mechanisms III ,” ed. Bronzetti G. , Hayatsu H. , DeFlora S. , Waters M. D. and Shankel D.M. , pp. 257 – 262 ( 1993. ). Plenum Press; , New York & London . [DOI] [PubMed] [Google Scholar]
  • 19. ) Mori , H. , Yoshimi , N. , Sugie , S. , Tanaka , T. , Morishita , Y. , Jinlong , G. , Tamai , Y. , Torihara , M. , Yamahara , J.Inhibitory effect of 5‐hydroxy‐4‐(2‐phenyl‐(E)ethenyl)‐2(5H)‐furanone, a novel synthesized retinoid, on azoxymethane‐induced intestinal carcinogenesis in rats . Cancer Lett. , 66 , 93 – 98 ( 1992. ). [DOI] [PubMed] [Google Scholar]
  • 20. ) Pretlow , T. P. , O'Riordan , M. A. , Somich , G. A. , Amini , S. B. and Pretlow , T. G.Aberrant crypts correlate with tumor incidence in F344 rats treated with azoxymethane and phytate . Carcinogenesis , 13 , 1509 – 1512 ( 1992. ). [DOI] [PubMed] [Google Scholar]
  • 21. ) Magnuson , B. A. , Carr , I. and Bird , R. P.Ability of aberrant crypt foci characteristics to predict colonic tumor incidence in rats fed cholic acid . Cancer Res. , 53 , 4499 – 4504 ( 1993. ). [PubMed] [Google Scholar]
  • 22. ) Bird , R. P.Further investigation of the effect of cholic acid on the induction, growth characteristics and stability of aberrant crypt foci in rat colon . Cancer Lett. , 88 , 202 – 209 ( 1995. ). [DOI] [PubMed] [Google Scholar]
  • 23. ) Shiff , S. J. , Koutsos , M. I. , Qiao , L. and Rigas , B.Nonsteroidal antiinflammatory drugs inhibit the proliferation of colon adenocarcinoma cells: effects on cell cycle and apoptosis . Exp. Cell Res. , 222 , 179 – 188 ( 1996. ). [DOI] [PubMed] [Google Scholar]
  • 24. ) Samaha , H. S. , Kelloff , G. J. , Steele , V. , Rao , C. V. and Reddy , B. S.Modulation of apoptosis by sulindac, curcu‐ min, phenylethyl‐3‐methylcaffeate, and 6‐phenylhexyl iso‐thiocyanate: apoptotic index as a biomarker in colon cancer chemoprevention and promotion . Cancer Res. , 57 , 1301 – 1305 ( 1997. ). [PubMed] [Google Scholar]
  • 25. ) Giardello , F. M. , Hamilton , S. R. , Krush , A. J. , Piantodosi , S. , Hylind , L. M. , Cleano , P. , Booker , S. V. , Robinson , R. C. and Offerhaus , G. J. A.Treatment of colonic rectal adenomas with sulindac in familial ad‐enomatosis polyposis . N. Engl J. Med. , 328 , 1313 – 1316 ( 1993. ). [DOI] [PubMed] [Google Scholar]

Articles from Japanese Journal of Cancer Research : Gann are provided here courtesy of Wiley

RESOURCES